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Alternative promoter usage generates long and short isoforms (DCLK1-L and DCLK1-S) of doublecortin-like kinase-1 (DCLK1). Tight
control of Notch signaling is important to prevent and restitute inﬂammation in the intestine. Our aim was to investigate whether
Notch1–DCLK1 axis regulates the mucosal immune responses to infection and whether this is phenocopied in human models of
colitis. In the FFPE (formalin-ﬁxed parafﬁn-embedded) sections prepared from the colons of ulcerative colitis (UC) and immunemediated colitis (IRAEC) patients, expression of DCLK1 isoforms correlated positively with Notch1 and negatively with a
transcriptional repressor, FoxD3 (Forkhead Box D3). DCLK1 protein staining in these sections was predominantly sub-epithelial
(stromal) wherein DCLK1 co-localized with NICD, CD68, CD11c, and neutrophil elastase (NE). NE also co-stained with CitrullinatedH3 indicating the presence of neutrophil extracellular traps. In human neutrophils, elevated levels of DCLK1-S, CXCL-10, Ly6G, MPO,
NE, and Notch1/2 in LPS-treated cells were inhibited when LPS was added in conjunction with Notch blocker dibenzazepine (DBZ;
LPS + DBZ group). In CR-infected Rag1−/− mice, higher levels of DCLK1 in the colonic crypts were inhibited when mice received
DBZ for 10 days coincident with signiﬁcant dysbiosis, barrier disruption, and colitis. Concurrently, DCLK1 immunoreactivity shifted
toward the stroma in CR + DBZ mice with predominance of DCLK1-S that coincided with higher Notch1 levels. Upon antibiotic
treatment, partial restoration of crypt DCLK1, reduction in MPO activity, and increased survival followed. When intestinal epithelial
cell-speciﬁc Dclk1-knockout (Dclk1ΔIEC) or Dclk1ΔIEC;Rag1−/− double knockout (DKO) mice were infected with CR and given a single
dose of DBZ, they developed barrier defect and severe colitis with higher levels of stromal DCLK1-S, Ly6G, NE, and Notch1. We
therefore propose that, by regulating the mucosal immune responses, the Notch–DCLK1 axis may be integral to the development
of murine or human colitis.
Cell Death Discovery (2021)7:169 ; https://doi.org/10.1038/s41420-021-00526-9

INTRODUCTION
Inﬂammatory bowel disease (IBD) is a polygenic disease. An
abnormal immune response mounted toward the luminal
microbiota in a genetically susceptible host may lead to the
onset and perpetuation of the disease [1, 2]. Tuft cells in the
intestine that exhibit strong expression of doublecortin-like
kinase 1 (DCLK1) [3] interact closely with cells of the immune
system [4–7] and their ablation impairs epithelial proliferation
and tissue regeneration after injury [8]. DCLK1 exists in long and
short isoforms (DCLK1-L and DCLK1-S) generated by two
alternative promoter usage with important differences between
the isoforms in both human and mouse tissues. During human
neoplasia, hypermethylation of DCLK1-L appears to cause a
predominant switch to the short isoform, which confers a more
invasive tumor phenotype [9] suggesting that DCLK1 isoforms
likely have distinct functions [10]. Indeed, DCLK1+ tuft cells
have recently been identiﬁed as new players in colitis [11]. Yet,
the mechanisms regulating the biology of the two isoforms
in murine or human models of colitis have not been clearly
elucidated.

Notch signaling plays a critical role in the maintenance of
epithelial integrity by regulating the balance of secretory and
absorptive cell lineages and also by facilitating epithelial cell
proliferation. In murine models of colitis, Notch is activated in
the inﬂamed mucosa to stimulate cellular proliferation and
regeneration of the tissue [12]. A recently published study clearly
demonstrated that inhibition of Notch signaling decreases
DCLK1+ cells following radiation injury [13] suggesting that
Notch–DCLK1 axis may be an important signaling mechanism for
crypt regeneration. Despite recent advances, many fundamental
questions remain about the biology of the DCLK1 isoforms and
whether Notch–DCLK1 axis regulates the mucosal immune
responses to infection.
Models of infectious colitis are crucial for deﬁning the
potentially pathogenic host responses to enteric bacteria. Infection with Citrobacter rodentium (CR), a noninvasive mouse
pathogen that belongs to the group of attaching and effacing
(A/E) bacteria, is one of the few available models of infectious
colitis [14, 15]. CR infection is used to model several important
human intestinal disorders, including Crohn’s disease, ulcerative
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colitis (UC), and more recently, colon tumorigenesis [16, 17].
Following CR infection, mice develop colitis [18], and this causes a
pronounced dysbiosis that is characterized by an overgrowth of
CR and a consequent reduction in the abundance and overall
diversity of the resident microbiota [19]. CR has become a model
microorganism to study how enteric A/E pathogens subvert
normal host cell functions, such as innate immunity, intestinal cell
shedding, and apoptosis, to colonize the host [14].
Employing this well-credentialed model of infectious colitis, we
previously demonstrated that chronic inhibition of Notch signaling coupled with decreases in DCLK1+ cells result in severe
inﬂammation, morbidity, and mortality in an outbred strain that
otherwise exhibits a self-limiting disease [20, 21]. These studies,
however, did not elaborate on the effect of DCLK1 deletion on
mucosal immune responses that regulate the outcome of
infectious colitis [10]. We therefore hypothesized that mice lacking
epithelial DCLK1 when challenged with CR infection may be highly
susceptible to epithelial Notch inhibition and develop severe
inﬂammation and colitis. Using both murine and human models of
colitis, we demonstrate that loss of epithelial but not stromal
DCLK1 synergizes with stromal Notch1 to regulate inﬂammatory
processes in the colon.
RESULTS
Differential expression of DCLK1 isoforms correlate positively
with Notch1 and negatively with Forkhead Box D3 (FoxD3)
expression
To understand the relationship between DCLK1 isoforms and
Notch signaling, we isolated total RNA from the formalin-ﬁxed
parafﬁn-embedded (FFPE) sections of either control subjects or
patients with UC or immune-related adverse events—colitis
(IRAEC) and discovered distinct changes in the expression of
DCLK1-L and DCLK1-S isoforms along with Notch1 and FoxD3,
respectively. As is depicted in Fig. 1Ai–iii, while we observed
elevated expression levels of both isoforms of DCLK1, DCLK1-S
was particularly expressed at higher levels in both UC and IRAEC
patients compared to control. These changes correlated with
Notch1 upregulation, and a dramatic decrease in the expression of
FoxD3 (Fig. 1A), a potent repressor of DCLK1-S expression in
normal cells [22]. To corroborate changes in RNA levels with
protein, we next stained 5 μm sections with antibodies against
DCLK1 and Notch intracellular domain (NICD) that transduces
Notch signaling initiated at the plasma membrane. As is depicted
in Fig. 1B, compared to control (Fig. 1Bi), DCLK1 and NICD colocalization increased in UC and IRAEC samples wherein the
protein staining was not only sub-epithelial (stromal) but
predominantly nuclear consistent with NICD’s role in nuclear
signaling (Fig. 1Bii, iii). Since DCLK1-L is a plasma membrane
protein [23], these ﬁndings suggest that DCLK1-S may be
predominantly co-localizing with NICD. As a corollary to this,
membrane-bound DCLK1 did not co-localize with NICD (Fig. S1A).
When sections were stained with antibody for Hes-1, the
downstream target of Notch signaling, we observed signiﬁcantly
more staining for Hes-1 both within the crypts and the subepithelial of colons from UC patients compared to control (Fig. 1C)
suggesting an active Notch signaling within the immune
compartment.
Next, we looked at DCLK1’s co-localization with markers of
macrophages and dendritic cells (DCs) in the sections from IBD
patients. Antibodies for epithelial cell adhesion molecule or CD45
were used to identify epithelial and immune cells, respectively
(Fig. S1B). In control sections, we detected sub-epithelial DCLK1
co-localization with both CD68 and CD11c, respectively (Fig. 2A,
B). In colonic sections from UC or IRAEC patients, there was weak
staining recorded for epithelial DCLK1 while sub-epithelial regions
exhibited signiﬁcant co-localization of DCLK1 with both CD68
and CD11c, respectively (Fig. 2A, B). Not all DCLK1+ cells however,

co-stained with markers of immune cells suggesting that these
DCLK1+ cells may have specialized roles and may synergize with
aberrant Notch signaling to inﬂuence stromal immune responses.
CR infection increases the expression of DCLK1, a tuft cell
marker, in the colons of immune-incompetent mice
To begin to understand the mechanistic basis of DCLK1–Notch
axis in vivo, we utilized a well-established model of infectious
colitis [18–20]. Rag-1−/− mice compared to either FVB/N or C3H/
HeN strains, when infected with CR, develop transient colitis and
crypt hyperplasia [24]. In response to CR infection, the distal
colons of Rag1−/− mice had crypt hyperplasia, as was evidenced
by hematoxylin and eosin (H&E) and Ki-67 staining (Fig. 3A, B).
Intriguingly, we discovered a signiﬁcant increase in DCLK1 staining
in the distal colons of these mice compared to uninfected controls
(Fig. 3C). This was conﬁrmed through ﬂow cytometry that revealed
an ~4-fold (1.85 vs. 7.17%) increase in DCLK1+ cells in the colonic
crypts isolated from CR-infected colon (Fig. 3D). In the immunecompetent Rag-1+/+ mice, however, we did not see any increase
in DCLK1 levels in response to CR infection compared to
uninfected controls (2.57 vs. 2.44%) (data not shown). We next
compared the extent of immune cell recruitment in the colons of
CR-infected wild-type (WT) and Rag-1−/− mice. As is depicted in
Fig. 3E, Gr1(Ly6G)+ cells representing granulocytes increased from
7.95% in uninfected controls to 13.3% in CR-infected mouse
colons from WT mice. In Rag-1−/− mice, this increase was modest
(8.57 vs. 10.1%; explained in 5C). Thus, CR infection upregulates
DCLK1 in Rag-1−/− vs. Rag-1+/+ controls in the colon that is not
necessarily overtly inﬂamed.
Blocking Notch signaling in vivo impairs CR’s proliferative
capacity by promoting goblet cell hyperplasia
Combining CR infection with Notch signaling blockade results
in disruption of the intestinal barrier and exacerbation of colitis
[20]. We replicated this experiment in Rag1−/− mice wherein CR
infection coupled with Notch inhibition with a γ-secretase
inhibitor dibenzazepine (DBZ) for 10 days revealed mucosal
inﬂammation and crypt abscess along with goblet cell hyperplasia in the CR + DBZ-treated colons compared to CR alone (Fig. 4A,
B). At the same time, the Ki-67 staining decreased signiﬁcantly in
the CR + DBZ-treated colons (Fig. 4C) compared to CR alone
despite no change in crypt lengths. Since DBZ is a Notch blocker,
we next investigated the effect of DBZ on components of Notch
signaling. Of the four Notch receptors, we discovered a signiﬁcant
increase in Notch1 mRNA (Fig. 4D) and NICD generation (Fig. 4E)
in the CR-infected crypts compared to uninfected controls that
led to an increase in relative abundance for Hes-1 (Fig. 4F). CR +
DBZ treatment decreased Notch1 mRNA, NICD, and Hes-1 levels
(Fig. 4D–F, respectively). These data suggest that inhibition of
epithelial Notch signaling that coincides with loss of crypt DCLK1
worsens CR-induced inﬂammation and suppresses proliferation in
Rag-1−/− mice.
Notch inhibition impairs barrier function and promotes
bacterial dissemination and neutrophil recruitment
To examine the consequence of Notch blockade in Rag-1−/− mice
on barrier function and bacterial dissemination, we performed
ﬂuorescein isothiocyanate (FITC) dextran assay and electron
microscopy on colonic tissues in groups of mice indicated in
Fig. 5. We observed a signiﬁcant increase in serum FITC dextran
levels in CR + DBZ colons compared to CR alone, indicating
increases in paracellular permeability (Fig. S1C). CR infection
disrupted the microvilli compared to uninfected controls
(Fig. 5Ai). When CR infection was coupled with Notch inhibition
by DBZ for 10 days, we discovered signiﬁcant bacterial invasion
toward the sub-epithelial regions some of which were associated
with immune cells (Fig. 5Aii). To conﬁrm whether these bacterial
populations belonged to Citrobacter, we stained the sections with
Cell Death Discovery (2021)7:169
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Fig. 1 Correlation of DCLK1 isoforms with components of Notch signaling in the colons of UC and IRAEC patients. A Total RNA from the
10 μm FFPE sections was isolated followed by real-time RT-qPCR of the indicated markers. The values were normalized to GAPDH and data are
presented as fold change. P values for Ai based on signiﬁcance (IRAEC): 0.0029 (DCLK1-S), 0.0004 (FoxD3), 0.00016 (Notch1). P values for Ai
based on signiﬁcance (UC): 0.0042 (DCLK1-L), 0.0011 (DCLK1-S), 0.0003 (FoxD3), 0.00003 (Notch1). P values for Aii based on signiﬁcance
(IRAEC): 0.014 (FoxD3), 00004 (Notch1). P values for Aii based on signiﬁcance (UC): 0.00013 (DCLK1-S), 0.000053 (FoxD3). P values for Aiii based
on signiﬁcance (IRAEC): 0.0015 (DCLK1-L), 0.000008 (DCLK1-S), 0.00044 (Notch1). P values for Aiii based on signiﬁcance (UC): 0049 (DCLK1-L),
0.00019 (DCLK1-S), 0.043 (FoxD3), 0.000029 (Notch1); n = 3 independent experiments. B Parafﬁn-embedded sections from control or immunemediated colitis (IRAEC) and ulcerative colitis (UC) patients were co-stained with antibodies for DCLK1 and NICD, respectively. Signiﬁcant colocalization of DCLK1 with NICD was recorded in the sub-mucosal (stromal) regions in the colons of IRAEC (Bii) or UC (Biii) patients compared
to control (Bi), shown as merged images (insets represent higher magniﬁcation of nuclear staining) while a subset of DCLK1+ cells did not colocalize with NICD (green staining). Scale bar = 100 μm; n = 2 independent experiments. C Representative images showing immunohistochemical staining of Hes-1, a downstream target of NICD. Scale bar, 80 μm; n = 2 independent experiments.

antibody to CR. As is depicted in Fig. 5B, sections from the
uninfected colon were negative for CR, while signiﬁcant CR
staining was recorded in the lumen of CR-infected colons. In
response to CR + DBZ, the CR staining extended into the crypts
Cell Death Discovery (2021)7:169

(Figs. 5B and S1D) and was associated with bacterial dissemination
to the liver (Fig. S1E). These changes were associated with a
signiﬁcant increase in C-X-C chemokine motif ligand 1 (CXCL1)/
keratinocyte (in mice) levels in both crypt and crypt-denuded
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Fig. 2 Immune cells associate with DCLK1 in the colons of UC and IRAEC patients. Parafﬁn-embedded sections from control or immunemediated colitis (IRAEC) and ulcerative colitis (UC) patients were co-stained with antibodies for DCLK1/CD68 and DCLK1/CD11c, respectively.
Nuclei were stained with DAPI (blue). Signiﬁcant co-localization of DCLK1 with both CD68 and CD11c representing macrophages and
dendritic cells, respectively, was recorded in the sub-mucosal (stromal) regions in the colons of IRAEC or UC patients compared to control (red
arrows) while a subset of DCLK1+ cells did not co-localize with either cell type (white arrows). Scale bar = 100 μm; n = 2 independent
experiments.

lamina propria (CLP) in response to CR and CR + DBZ while
changes in CXCL9/10 expression were less signiﬁcant (Fig. S1F, G).
When CR + DBZ mice were subjected to a cocktail of antibiotics, no
such staining was observed (Fig. 5B). Since CXCL1 recruits
neutrophils to the inﬂamed site [25], we isolated the CLP from
the colons, and single cells were labeled with anti-Ly6G followed
by ﬂow cytometry. As is depicted in Fig. 5C, we discovered

increases in Gr1(Ly6G)+ myeloid cells in the CR + DBZ group,
which led to a signiﬁcant increase in myeloperoxidase (MPO)
activity compared to either CR or uninfected controls (Fig. 5D). In
response to antibiotics, a decrease in MPO activity (Fig. 5D) and
increased survival (data not shown) was observed in the CR + DBZ
+ Abx colons. Thus, barrier disruptions and bacterial dissemination
accompany neutrophil recruitment/degranulation when CR
Cell Death Discovery (2021)7:169
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Fig. 3 Citrobacter rodentium (CR) induced changes in gross morphology and DCLK1 expression. Representative H&E (A), Ki-67 (B), and
DCLK1 (C) immunostaining of distal colons from uninfected (N) or CR-infected Rag1−/− mice (scale bar 100 μm; 7–8 mice/group; n = 3
independent experiments). D Representative ﬂow cytometry performed in crypt epithelial cells isolated from uninfected or CR-infected Rag1-/mouse colons for DCLK1 (lower panel represents the gating strategy). E Representative ﬂow cytometry performed in the colons of uninfected
or CR-infected wild-type C57BI/6j for Gr1(Ly6G).

infection is coupled with inhibition of epithelial Notch signaling in
Rag-1−/− mice.
Chronic notch inhibition induces gut dysbiosis concomitant
with alterations in crypt DCLK1
In the stools collected from the CR-infected or CR + DBZ-treated
groups, we observed signiﬁcant dysbiosis with reduced levels of
Bacteroidetes (15 and 18% compared to 57%) and Firmicutes (32
and 13% compared to 36%) accompanied by dramatic increases
in Proteobacteria phyla (43 and 68% compared to 2%) (Fig. 6A).
In particular, we discovered the Enterobacteriaceae family to be
overrepresented in the CR + DBZ group (Fig. 6A). Principal
coordinate analysis revealed a signiﬁcant separation of microbial
communities in fecal samples from CR + DBZ mice when
compared to either uninfected or CR-infected mice (P value =
0.001; Fig. 6B). Interestingly, a controlled regimen of antibiotics
cocktail (CR + DBZ + Abx) mitigated dysbiosis in CR + DBZCell Death Discovery (2021)7:169

treated Rag1−/− mice, with increases in Bacteroidetes (31 vs.
16%) and Firmicutes (26 vs. 12%) and decreases in Proteobacteria
(41 vs. 72%) (Fig. S2A). We next performed ﬂuorescence in situ
hybridization (ISH) analysis using a ubiquitous eubacterial probe
EUB338. Results revealed only a small number of bacteria
invading the colonic crypts in the CR group (Fig. 6C). In the CR +
DBZ group, increases in bacterial invasion into the crypts were
signiﬁcantly reduced in the CR + DBZ + Abx group (Fig. 6C).
Immunohistochemistry performed on tissue sections prepared
from CR-infected mouse colon revealed a signiﬁcant increase in
DCLK1 staining compared to uninfected control (Fig. 6D)
consistent with data shown in Fig. 3C, D. In the CR + DBZ
group, signiﬁcant reduction in DCLK1 expression was observed
in the colonic crypts (Fig. 6D) as was also conﬁrmed via ﬂow
sorting wherein the number of DCLK1+ cells in the crypts
decreased from 10.5% in the CR group to 5.42% in the CR + DBZ
group (Fig. 6E). In addition to DCLK1, CR infection also promoted

B.C. Roy et al.
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Fig. 4 Effect of Notch blockade on signaling parameters. Representative H&E (A), Alcian blue (B), and Ki-67 (C) staining of uninfected (N), CRinfected (CR), or CR + DBZ-treated (CR + DBZ) Rag1−/− mice (scale bar 100 μm; 7–8 mice/group; n = 3 independent experiments). D Total crypt
RNA from the same group of mice was isolated and Notch1 expression was investigated via real-time RT-qPCR. The values were normalized to
GAPDH and data presented as fold change. P values = 0.000004 (Notch1), 0.000091 (Hes1); n = 3 independent experiments. E Western blot
analysis of NICD in the isolated crypts in the indicated group. β-Actin was used as the loading control. Lower panel. Densitometry showing
relative abundance. *,**P < 0.05; n = 3 independent experiments. F Real-time RT-qPCR of Notch downstream target Hes-1 in the isolated crypts
from the indicated groups. P values = 0.000091 (Hes1); n = 3 independent experiments. Lower panel showing western blot of Hes-1 and Math1 in the crypts isolated from the indicated groups. Lamin B was used as the loading control (n = 3 independent experiments).

Lgr5 expression, and the expression was attenuated in the CR +
DBZ group (Fig. S2B). Thus, a loss of both crypt DCLK1-L and
Lgr5 in the CR + DBZ group suggests that the mucosal
regenerative capacity may be signiﬁcantly compromised [26].
Interestingly, antibiotic treatment led to a decrease in Proteobacteria while both Firmicutes and Bacteroidetes showed an
improvement, and these changes correlated with partial
restoration of DCLK1+ cells compared to the CR + DBZ group

(Fig. 6E). Thus, loss of crypt DCLK1 following inhibition of
epithelial Notch signaling coincides with bacterial dysbiosis and
severity of colitis.
Crypt vs. stromal DCLK1 and changes in immune proﬁle in
response to CR infection and/or acute Notch inhibition
To investigate whether the expression of DCLK1 is critical in
maintaining crypt integrity, we bred DCLK1ﬂ/ﬂ mice with CDX2Cell Death Discovery (2021)7:169
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Fig. 5 Effect of Notch blockade on bacterial colonization, neutrophil recruitment, and myeloperoxidase (MPO) activity. Ai Electron
microscopy of distal colons isolated from uninfected (N), CR-infected (CR), CR + DBZ-treated (CR + DBZ), or CR + DBZ plus antibiotics (CR +
DBZ + Abx)-treated Rag-1−/− mice. Loss of microvilli structure in response to CR infection was exacerbated following Notch inhibition in the
CR + DBZ group with clear bacterial invasion into the sub-mucosa. Antibiotics (Abx) treatment restored the microvilli. Aii represents the EM of
distal colon from the CR + DBZ group showing interaction of bacteria with immune cells (6 mice/group; n = 3 independent experiments).
B Representative images showing bacterial staining by anti-CR antibody (αCR). C Flow cytometry for Gr1(Ly6G)+ cells was performed in the
colon tissues of uninfected (N), CR-infected (CR), or CR + DBZ-treated (CR + DBZ) Rag-1−/− mice. D MPO activity was measured in the colonic
homogenates of the indicated groups using a Fluoro MPO Detection Kit (6 mice/group; n = 3 independent experiments).

Cre/ERT2 to generate DCLK1ΔIEC mice upon tamoxifen-induced
Cre recombination (Fig. S3A). Since DCLK1 was signiﬁcantly
overexpressed in Rag-1−/− mice in response to CR infection, we
further bred DCLK1ﬂ/ﬂ;CDX2-Cre/ERT2 mice with Rag1−/− to
generate double knockout (DKO) mice to see whether the
DKOs are more susceptible to infectious colitis. Figure S3B–E
depict the genotypes of various crosses and a representative
image of the DCLK1 staining in DCLK1ﬂ/ﬂ and DCLK1ΔIEC mice,
respectively. In response to CR infection, both DCLK1ΔIEC and
DKO mice had signiﬁcant gross thickening of the colon (Fig. 7Ai,
Bi), elongated crypts showing elevated Ki-67 labeling, and
goblet cell hypoplasia associated with loss of Muc-2 (Fig. 7Aii,
Bii). We also detected signiﬁcant CR staining in the lumen of CRinfected colons compared to the uninfected colon with some
penetration into the crypts. When CR-infected mice were given
Cell Death Discovery (2021)7:169

a single dose of DBZ, more severe phenotypes were observed
(Fig. 7Aii, Bii) that paralleled changes recorded in Rag1−/− mice
after 10 consecutive days of DBZ (see Figs. 6 and S1) indicating
that loss of crypt DCLK1 severely impacts the disease process. In
the absence of CR infection, however, DBZ alone did not have
any associated pathology (data not shown) [19]. Interestingly,
loss of crypt DCLK1 did not impact Lgr5 expression in
CR-infected crypts (Fig. S4A); CR + DBZ treatment, however,
led to a severe reduction in Lgr5 expression (Fig. S4A) as was
reported elsewhere (see Fig. S2B). This was further corroborated
in an organoid assay wherein the CR + DBZ group exhibited
degeneration of the enteroids compared to the CR group
(Fig. S4B).
Despite the loss of crypt DCLK1 in DCLK1ΔIEC mice, we
discovered stromal presence of DCLK1+ cells in CD11c+;MHCII+

B.C. Roy et al.
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Fig. 6 Microbial dysbiosis coincides with downregulation of crypt DCLK1 following Notch blockade. A Fecal samples from uninfected (N),
CR-infected (CR), and CR + DBZ-treated mice were subjected to 16S rDNA sequencing and relative abundance of phyla and families were
compared. Each chart represents the taxonomic composition in the indicated groups (n = 10 mice/group). B Principal coordinate analysis
(PCoA) based on weighted UniFrac distances between bacterial communities. Please note signiﬁcant separation of microbial communities in
fecal samples from CR + DBZ mice when compared to either uninfected (N) or CR-infected (CR) mice (P < 0.05). C The bacteria in the colonic
tissues of N, CR, CR + DBZ, and CR + DBZ + Abx-treated mice were detected by FISH using a general bacterial 16S probe (red, TexasRedEub338; bar = 100 μm; n = 3 independent experiments). DAPI was used as counterstain. D Representative images of DCLK1 staining in the
distal colons of the indicated groups (n = 10 mice/group). E Flow cytometry showing percentages of DCLK1+ cells isolated from the groups of
mice indicated (n = 10 mice/group).

DCs, F4/80+;MHCII+ macrophages, and Gr-1(Ly6G)+ neutrophils
wherein there was a predominance of DCLK1-S in the sorted cells,
particularly in Ly6G+ neutrophils (Fig. 7C). Interestingly, in vitro
studies in cultured bone marrow-derived cells (BMDCs; Fig. S5A)
only detected DCLK1-S in CR-infected cells, and the levels declined
in response to CR + DBZ (Fig. S5B). In CLP, although we detected

both the isoforms, only the DCLK1-S levels were induced by CR
infection with an ~40% reduction in the levels after CR + DBZ
treatment (Fig. S5B) paralleling those recorded in vivo (see Fig. 6).
Since stromal DCLK1-L was not affected by either treatment, these
ﬁndings suggest that DCLK1-S may be the target of Notch
dysregulation within the stromal region. In DKO mice, DCLK1-S
Cell Death Discovery (2021)7:169
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Fig. 7 Effect of DCLK1 deletion on mucosal inﬂammation and colitis. Control (ﬂoxed) or intestinal epithelial cell-speciﬁc DCLK1-KO
(DCLK1ΔIEC) or DCLK1Δ IEC;Rag-1−/− double KO (DKO) mice were infected with CR and given single doses of DBZ. Ai, Bi Gross thickening and
ulceration of the colon in the two transgenic lines. Aii, Bii Representative histology (H&E) or immunostaining in the parafﬁn-embedded
sections prepared from the distal colons of the indicated mouse groups. Alcian blue and Ki-67 labeling represents goblet and proliferating
cells, respectively. Anti-CR- and α-Muc2-stained Citrobacter rodentium and Muc-2, respectively (n = 6 mice/group; Scale bar: 100 μm). C, D
Immune cells were FACS-sorted with antibodies against CD11c, F4/80, and Ly6G from the crypt-denuded lamina propria of the indicated
groups of mice and the expression of the two isoforms of DCLK1 were measured by RT-qPCR. The values were normalized to GAPDH, and data
are presented as fold change. P values for C based on signiﬁcance: 0.000033 (CD11c: DCLK1-S), 0.000057 (F4/80: DCLK1-S), 0.013 (Ly6G: DCLK1L), 0.0081 (Ly6G: DCLK1-S). P values for D based on signiﬁcance: 0.000035 (CD11c: DCLK1-S), 0.016 (F4/80: DCLK1-S), <0.000001 (Ly6G: DCLK1S); n = 3 independent experiments.

Cell Death Discovery (2021)7:169
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Fig. 8 Evidence of neutrophil extracellular trap formation in vivo. A–C Human neutrophils were cultured in the presence or absence of LPS
or LPS + DBZ for 8 h and the expression of indicated markers was determined by RT-qPCR and the data are presented as fold change after
normalizing values to GAPDH. P values for A based on signiﬁcance (LPS vs. control): 0.000734 (DCLK1-L), 0.023915 (DCLK1-S), 0.004097
(FoxD3); LPS + DBZ vs. LPS: 0.000525 (DCLK1-L), 0.057920 (DCLK1-S), 0.000035 (FoxD3). P values for B based on signiﬁcance (LPS vs. Control):
0.000024 (NE), 0.000115 (Notch1); LPS + DBZ: 0.000083 (NE), 0.000075 (Notch1). P values for C based on signiﬁcance (LPS vs. Control): 0.003059
(CXCL9), 0.000883 (CXCL10); LPS + DBZ vs. LPS: 0.007031 (MPO), 0.000315 (Notch2). D–I Parafﬁn-embedded sections from control or UC and
immune-related adverse event—colitis (IRAEC) patients were co-stained with antibodies for DCLK1/NE or NE/Cit-H3, respectively. Solid arrows
provide evidence of co-localization; open arrows point to DCLK1+ cells that did not co-localize with NE (Scale bar = 150 μm; n = 2
independent experiments).

was consistently upregulated in CD11c+ and Ly6G+ cells
(Fig. 7D). Intriguingly, we also observed the expression of
DCLK1-L isoform (Fig. 7D), particularly in the Ly6G+ cells in the
CR group, and its expression was not affected by DBZ (Fig. 7D). To

see whether the two isoforms can also be regulated by
proinﬂammatory cytokines, we next performed an in vitro assay
wherein we observed interleukin-6-induced increases in both
DCLK1-L and DCLK1-S promoter reporter activities, respectively
Cell Death Discovery (2021)7:169
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(Fig. S5C). Taken together, CDX2-Cre-dependent KO of epithelial
DCLK1 does not preclude accumulation of the two isoforms within
the sub-epithelial region at least at the RNA level and that this
may be inﬂuenced by immune cell recruitment.
Since Ly6G+ neutrophils had the highest levels of DCLK1-S, we
next corroborated these ﬁndings in vitro wherein we treated
human neutrophils with lipopolysaccharide (LPS) and DBZ and
analyzed the expression proﬁles of the two DCLK1 isoforms and
other relevant genes. As is depicted in Fig. 8A, LPS signiﬁcantly
increased both DCLK1-L and DCLK1-S isoforms along with 51- and
76-fold increases in neutrophil elastase (NE) and Notch1,
respectively (Fig. 8B). In addition, we observed signiﬁcant
increases in CXCL10, Ly6G, MPO, and Notch2 in response to LPS
(Fig. 8C). When LPS was combined with DBZ, DCLK1-L expression
was not affected by DBZ (Fig. 8A). DCLK1-S levels, however, were
mildly reduced upon DBZ treatment along with a reduction in NE,
Notch1 and 2, CXCL10, Ly6G, and MPO expression, respectively
(Fig. 8A–C) suggesting that these genes may be regulated by
Notch signaling. In contrast, we saw signiﬁcant downregulation of
FoxD3 in LPS-treated samples and the expression was further
reduced in the LPS + DBZ group (Fig. 8A). These results are in
complete contrast to our ﬁndings in colonic crypts wherein we
showed that membrane-bound DCLK1 is reduced upon DBZ
treatment (Fig. 6D, E) suggesting that the two isoforms may be
regulated differently in the epithelial vs. non-epithelial/stromal
compartments. Since neutrophils besides providing a front line of
defense against bacterial infection also act as mediators of
inﬂammation [27], we next studied co-localization of NE with
DCLK1 and Citrullinated-H3 (Cit-H3) to detect neutrophil extracellular trap (NET) formation in the FFPE sections. As is depicted in
Fig. 8D–F, compared to control, we saw signiﬁcant co-localization
of NE with DCLK1 in both UC and IRAEC. NE also co-localized with
Cit-H3 in both UC and IRAEC (Fig. 8G, H) consistent with
neutrophilic inﬂammation seen in immune-mediated colitis
patients [28]. These results provide an insight into which
neutrophils’ recruitment into the colons may contribute toward
tissue damage and severity of colitis.
DISCUSSION
Tuft cells interact closely with cells of the immune system and
expand during chronic inﬂammation [29]. Yet, neither their
biology nor the mechanism of their action is clearly understood.
Recent studies have speculated that these cells, marked by DCLK1,
may serve as a source of Notch signaling for Lgr5+ stem cells
following removal of Paneth cells [30]; yet, the signaling
mechanisms remain underexplored.
Employing human and murine models of colitis, we discovered
that the two isoforms of DCLK1 are expressed differently in the
epithelial vs. sub-epithelial regions of the inﬂamed mucosa. We
also provide evidence that microbial imbalance induced by an
enteric pathogen synergizes with loss of crypt DCLK1 and Notch
dysregulation to promote deviant or aberrant immune activation
that accompanies development of colitis. In response to CR
infection, there was an expansion of the DCLK1+ cells reminiscent
of tuft cell hyperplasia seen in the small intestine in response to
parasitic infection [3, 5]. The increase in crypt DCLK1 was
signiﬁcantly inhibited when CR-infected mice were given ten
doses of Notch blocker DBZ and coincided with microbial
dysbiosis, barrier disruption, and release of proinﬂammatory
mediators suggesting that Notch signaling is a critical intermediary pathway in gut dysbiosis regulation of DCLK1 expression. This
is consistent with a recent report wherein DCLK1 was shown to
mitigate mucosal barrier dysfunction by promoting intestinal
repair to counter chronic inﬂammation [11]. Moreover, the
observation that both DCLK1ΔIEC mice and DKOs became
hypersensitive to single doses of DBZ further portends that tight
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control of Notch signaling is important to prevent or restitute
inﬂammation in the gut.
Notch signaling has recently been implicated in the control of
several innate cell populations [31]. In the current study, we
observed various immune cell populations, including macrophages, DCs, and particularly neutrophils to express DCLK1-S
isoform. In vitro studies in neutrophils further provided evidence
that LPS-induced increases in DCLK1-S isoform but not the
DCLK1-L variant was reduced in cells treated with LPS + DBZ.
This is in contrast to the downregulation of DCLK1 in the crypt
epithelial cells isolated from CR + DBZ-treated mice (see Fig. 6D,
E). Interestingly, expression of several genes, including FoxD3,
CXCL10, Ly6G, MPO, NE, and Notch1/2, were reduced when the
Notch pathway was blocked, thereby indicating that they may be
involved in DCLK1-S regulation. FoxD3 in particular has recently
been reported to inhibit the transcriptional activity of the
DCLK1’s β-promoter thereby repressing DCLK1-S expression [22].
While available data indicate that loss of FoxD3 due to epigenetic
silencing promotes overexpression of the DCLK1-S variant in
human colon cancer cells [22], no such data exist in non-cancer
models. Thus, although a limitation of our study, it is nonetheless
tempting to speculate that increases in DCLK1-S seen in the
current study may be a result of epigenetic silencing of the
FoxD3 gene.
Neutrophils play both protective and detrimental roles in
mucosal homeostasis. Antimicrobial activity of neutrophils is
mediated by phagocytosis, the release of reactive oxygen species,
and lytic enzymes, as well as the formation of NETs composed of
DNA, histones, and granular proteins, such as NE [32]. This is
consistent with recent reports describing excessive NE activity
associated with tissue damage in a murine model of colitis [33]
and intraepithelial inﬁltration of human NE (HNE)+ cells in UC
patients [34]. Along these lines, NE not only co-localized with
DCLK1 in the colons of both UC and IRAEC patients but also
exhibited co-localization with Cit-H3 consistent with neutrophilic
inﬂammation seen particularly during IRAEC [35]. Whether Notch
signaling is deﬁnitively involved in NET formation in these colons
remains to be determined. Our discovery that DCLK1 co-localized
with NICD in the colons of both UC and IRAEC patients does,
however, provide a clue to the possibility that it may facilitate NET
formation in a Notch-dependent manner to regulate mucosal
inﬂammation. A recent study supporting this notion elegantly
demonstrated that macrophage-speciﬁc deletion of RBP-J, a
transcription factor that signals through Notch receptors, leads
to impaired innate and adaptive immune responses, thereby
impacting bacterial clearance [36].
Since gut bacteria are critical for the development of colitis as
their depletion leads to attenuation of the inﬂammatory
processes, we acknowledge the limitation of our study to fully
implicate gut microbiome changes associated with aberrant Notch
signaling in either the development or progression of colitis in
transgenic mouse lines. To this end, we did, however, see
moderate increase in DCLK1+ cells in Rag-1−/− mice treated with
antibiotics (see Fig. 6E) suggesting that restoring crypt DCLK1 may
help attenuate infectious colitis. Our ﬁndings also indicate that
stromal Notch activity fueled by immune cell recruitment,
particularly neutrophils, may synergize with DCLK1-S to regulate
the severity of infectious colitis. We corroborated some of these
ﬁndings in the colons of UC and IRAEC patients to further establish
the translational nature of our study. In conclusion, while DCLK1
has mostly been studied as a marker of tuft cells [3–8], our
ﬁndings indicate that DCLK1 isoforms likely have distinct
functions, and the expression of these isoforms may occur in
different cellular compartments that may not all represent tuft
cells. Thus, while more studies are needed to characterize the role
of DCLK1 isoforms as immune sentinel to connect intestinal lumen
with immune cells in the underlying tissue, we posit that loss of
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Table 1.

List of primers used in the study.

Genes

Forward primers

Human Dclk1-L

aaacggctcattcctttgag

Reverse primers
agtcctgaaggcacatcacc

Mouse Dclk1-S

gtcagccttacgcaggaaaa

tgggaagcagttggattagc

Human Dclk1-S

aggcatctgctgatgaatcc

tctcagcactaagccaagca

Mouse NE

gcactggcctcagagattgt

cagaaatgacctccacgcct

Human NE

aacgtctgcactctcgtgag

gaaggaggcaattccgtgga

Mouse FoxD3

tgcagctacagctcaacacc

tgttctcgatgctgaacgac

Human FoxD3

caaccgcttcccctactaca

gggatcttgacgaagcagtc

Mouse Cxcl-1

cttgaaggtgttgccctcag

tggggacaccttttagcatc

Mouse Cxcl-9

acggagatcaaacctgccta

tttttccccctcttttgct

Human Cxcl-9

gagtgcaaggaaccccagta

ttggggcaaattgtttaagg

Mouse Cxcl-10

gctgcaactgcatccatatc

cgtggcaatgatctcaacac

Human Cxcl-10

ccccacgttttctgagacat

aaggcagcaaatcagaatgg

Mouse MPO

tacccccgagactttgtcag

atagcacaggaaggccaatg

Human MPO

aggacaaataccgcaccatc

gaagagagaagccgtcctca

Mouse Notch2

cctgaacgggcagtacattt

gcgtagcccttcagacactc

Human Notch2

tatatttgcacctgcccaca

ttttcctgcatgctcacaag

Mouse GAPDH

aactttggcattgtggaagg

acacattgggggtaggaaca

Human GAPDH

aggctggggctcatttgcagg

tgaccttggccaggggtgct

For genotyping
Cdx2 transgene

acatgtccatcaggttcttgc

aggagccagcggagcac

Dclk1

cttcccactgatatgttcattc (Mutant)

agtgagatggtttacaggcaag (Common)

Rag1

tggatgtggaatgtgtgcgag (Mutant)

cattccatcgcaagactcct (Common)

epithelial but not stromal DCLK1 synergizes with stromal Notch1
to regulate inﬂammatory processes in the colon.
MATERIALS/SUBJECTS AND METHODS
Mouse models and procedures
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. All protocols were
approved by the University of Kansas Medical Center Animal Care
and Use Committee. All efforts were made to minimize suffering.
WT C57Bl/6j and B6.129S7-Rag1tm1Mom/J (Rag-1−/−) mice were
procured from Jackson Laboratory, Bar Harbor, ME, USA. The
DCLK1-ﬂoxed mice (DCLK1tm.2Jgg; stock#013170) surrounding
exon 3 of the DCLK1 gene were crossed with CDX2-Cre/ERT2 (B6.
Cg-Tg; CDX2-Cre/ERT2)752ERF/J) mice to obtain colon-speciﬁc KO
of DCLK1 (DCLK1ΔIEC). Further, we bred DCLK1ﬂ/ﬂ;CDX2-Cre mice
with Rag1−/− to generate DCLK1ﬂ/ﬂ;CDX2-Cre;Rag1−/− DKO mice.
The progeny was genotyped for both the presence of ﬂoxed site
and CDX2-Cre recombinase by tail-tip biopsies using the set of
primers described in Table 1. WT littermates or transgenic mice
(C57BL/6J background; 5–6 weeks old) received sterile culture
medium or were infected by oral inoculation with a 16-h culture of
CR (biotype 4280, ATCC, 108 colony-forming units), identiﬁed as
pink colonies on MacConkey agar, as previously described [17–
21, 27, 28] coupled with tamoxifen injection (intraperitoneally (i.p.;
(75 mg/Kg; 2 doses, alternately at postinfection days 3 and 5) for
conditional gene KO. To block Notch signaling in vivo, WT, Rag1−/
−
mice (10 doses; beginning at 2 days post-CR infection), or
transgenic lines (single dose; postinfection day 6) were treated
with cell-permeable γ-secretase inhibitor, DBZ (EMD Chemicals,
Inc.) [37] i.p. at 10 μmol/Kg of body weight suspended in 0.5% (wt/
vol) hydroxypropyl-methylcellulose and 0.1% Tween-80 in water
(wt./vol.).

Bacterial DNA extraction and microbiota analysis using
genomic DNA
Total genomic bacterial DNA from fresh feces was extracted using
the QIAmp DNA Stool Kit (Qiagen, Valencia, CA). DNA solutions
were stored at −80 °C until further processing. Using gDNA, the V4
region of the 16S rRNA encoding gene was ampliﬁed with
barcoded universal bacterial primers followed by sequencing on
Ion Torrent platform [19]. The resulting raw sequence ﬁles (.fastq.
gz) are being submitted to the NCBI Sequence Read Archive (SRA)
database. The raw sequences were analyzed using Quantitative
Insights Into Microbial Ecology (QIIME)-2 pipeline [38].
EUB338 staining and ISH
For EUB338 staining, parafﬁn sections were dewaxed and
rehydrated in an ethanol to water gradient. The tissue sections
were incubated with 5 μg/ml Texas Red-conjugated EUB338 (5′GCTGCCTCCCGTAGGAGT-3′, Sigma-Aldrich) in hybridization buffer
(0.1 M Tris-HCl, 0.9 M NaCl, 0.1% SDS, and 10% formamide, pH 7.2)
at 40 °C overnight. The sections were rinsed in washing buffer
(20 mM Tris-HCl, 0.9 M NaCl, pH 7.4) at 40 °C for 15 min, stained
with 1 μg/ml 4,6-diamidino-2-phenylindole and mounted with
Prolong Gold mounting medium (Invitrogen) [21]. ISH analysis was
performed as described [21]. Images were obtained and analyzed
with a Nikon i80 microscope.
Electron microscopy
Samples of the distal colon from various regimens were minced
into small cubes, ﬁxed in 4% paraformaldehyde and 2%
glutaraldehyde in cacodylate buffer (0.1 M sodium cacodylate,
pH 7.6) overnight at room temperature, postﬁxed in 1% osmium
tetroxide for 90 min, dehydrated through a graded series of
ethanol, embedded in epon-araldite resin, and maintained for 48 h
at 60 °C to polymerize. Ultra-thin (100 nm) sections cut on a Leica
UC-6 ultramicrotome were put on glow discharged 300 mesh
copper grids and stained with uranyl acetate and Sato’s lead to
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enhance contrast. Ultra-thin sections were examined with a JEOL
JEM-1400 electron microscope.
Crypt and CLP isolation, ﬂow cytometry and organoid assay
Crypts representing epithelial cells were isolated from distal
colons as described [17–21, 27, 28]. Following crypt removal, the
CLP was extracted, and both isolated crypts and CLPs were
processed for biochemical and molecular assays [18]. For ﬂow
cytometry or organoid assay, isolated crypts were either stained
with appropriate antibodies and data were analyzed on FACS Aria
III ﬂow cytometer (BD Biosciences) using the FlowJo software (BD
Biosciences) or cultured in organoid culture media (STEMCELL
Technologies Inc.) [21].
BMDC isolation and culture and experiments with human
neutrophils
To obtain BMDCs, bone marrow was isolated by ﬂushing with
RPMI with a syringe from mouse femur, cultured in RPMI-1640
media with 10% fetal bovine serum and penicillin–streptomycin,
and supplemented with 20 ng/ml of granulocyte macrophages
colony-stimulating factor (R&D System) for 7 days [39, 40]. Cells
were infected with CR for 3 h, washed and treated with DBZ
(50 nM) for 24 h, and washed, and cellular extracts were subjected
to western blotting. Human neutrophils were treated with LPS
(10 μg/ml) or LPS + DBZ (50 nM) for 8 h before RNA isolation and
quantitative PCR (qPCR) [21].
Histology, immunohistochemistry, and immunocytochemistry
For histology, tissues were ﬁxed in 10% neutral buffered formalin or
Carnoy’s ﬁxative (60% methanol, 30% chloroform, and 10% acetic
acid) before parafﬁn embedding. Images were obtained with an
Eclipse i80 microscope (Nikon Instruments, Melville, NY, USA).
Parafﬁn-embedded 5-μm-thick sections were stained with H&E for
gross morphology and with Alcian blue to detect goblet cells.
Immunohistochemistry and immunocytochemistry were performed
with appropriate antibodies on parafﬁn-embedded sections
[18, 21]. Antibodies used were rabbit anti-DCLK1 (1:200, ab31704)
and Anti-CR (1:250, ab37056) from Abcam, Cambridge, UK; mouse
anti-Notch1 NICD (1:200, clone OTI3E12) from Origene, Rockville,
MD; rabbit anti-Hes1 (1:200, #11988) and mouse anti-Ki-67 (1:200,
#9449) from Cell Signaling Technology, Danvers, MA; anti-CD68
(1:200, NB600-985) from Novus Biologicals (Littleton, CO, USA), AntiMuc2 and anti-NE (1:200) Santa Cruz, Dallas, TX; Anti-CD11c and
anti-F4/80 (Thermo Fisher), and anti-Ly6G (R&D, Minneapolis, MN).
Antibody controls included omission of the primary antibody or
detection of endogenous IgG staining with goat anti-mouse or antirabbit IgG (Calbiochem, San Diego, CA, USA).
Measurement of MPO activity
MPO activity was measured in whole-colon tissue homogenates
by a modiﬁcation of the method of Grisham et al. [41]. Brieﬂy,
colon homogenate was sonicated in 1% hexadecyltrimethylammonium bromide buffer and centrifuged at 12,000 rpm at 4 °C for
20 min. MPO activity in the homogenates was measured in
triplicate using a Fluorescent MPO Detection Kit (Fluoro MPO, Cell
Technology) according to the manufacturer’s instructions.
Patient samples
De-identiﬁed tissue sections from UC patients were procured from
Children’s Mercy Hospital, Kansas City, MO through an approved
Institutional Review Board according to institutional guidelines. FFPE
de-identiﬁed sections (5 and 10 μm) from UC and IRAE patients that
developed immune-mediated colitis (IRAEC), respectively, were
obtained from The University of Kansas’ Biospecimen Repository
Core Facility. For isolating RNA from the FFPE sections, we employed
PureLink FFPE RNA Isolation Kit (Cat# K156002; ThermoFisher
Scientiﬁc), according to the manufacturer’s instructions and the
RNAs were subjected to reverse transcriptase-qPCR as described [21].
Cell Death Discovery (2021)7:169

Statistical analysis
The values are expressed as mean ± SD. Statistical analyses of all
studies were performed using unpaired, two-sided Student’s t tests
[18] or one-way analysis of variance (ANOVA) models for multiplegroup comparisons. Linear contrasts with Bonferroni corrections for
multiple testing were for pairwise comparisons of groups based on
parameter estimates from one-way ANOVA model ﬁts. The
D’Agostino and Pearson omnibus K2 tests were used to assess the
assumption of normality. P < 0.05 was considered statistically
signiﬁcant. Sample size was determined based on the results from
pilot studies with similar mouse numbers. All experiments used n =
5 mice per group unless otherwise indicated in the ﬁgure legends
and are representative of 2–3 independent experiments. For in vivo
studies, reported sample number per experiment represent biologic
replicates (comparison of animals of one genotype with littermates
of another genotype). Both male and female mice were used in the
study. All analyses were performed using GraphPad, version 9.
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